Search
Search Results
##search.searchResults.foundPlural##
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2211PDF: 928HTML: 290 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1370PDF: 807HTML: 8649Fig 3 Savini: 166Fig 2 Savini: 172Fig 1 Savini Chest TC: 178Author letter to referees: 182 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1745PDF: 560HTML: 271 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2638PDF: 963HTML: 4696 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1933PDF: 704HTML: 675Table1: patient's characteristics: 152Table 2: profile of each patient: 176 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1428PDF: 1043HTML: 210 -
Osteolytic bone lesions – A rare presentation of AML M6.
1957PDF: 1085HTML: 7910Untitled: 200 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2213PDF: 872HTML: 1993Fig 1 Rossi: 172 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2804PDF: 843HTML: 6510Untitled: 221Untitled: 182Untitled: 197Untitled: 204 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1361PDF: 1295HTML: 90 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3191PDF: 1325HTML: 4121 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1279PDF: 1182HTML: 437 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2778PDF: 1000HTML: 5510 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4257PDF: 1361HTML: 2031 -
Severe eosinophilia in a case of giardiasis
1036PDF: 1540HTML: 413 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4655PDF: 2805HTML: 2268 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1160PDF: 714Html: 90 -
-
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2051PDF: 1106HTML: 7684cover letter paper final AML: 211 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1621PDF: 1164HTML: 191 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1491PDF: 525HTML: 263







